1 / 2

Hormone Replacement Therapy Market

The global hormone replacement therapy market size was valued at USD 22 billion in 2019 and is anticipated to expand at a CAGR of 7.5% during the forecast period, 2021u20132028. The growth of the market is attributed to the hormonal imbalance disorders such as menopause.

Télécharger la présentation

Hormone Replacement Therapy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hormone Replacement Therapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast The global hormone replacement therapy market size was valued at USD 22 billion in 2019 and is anticipated to expand at a CAGR of 7.5% during the forecast period, 2021–2028. The growth of the market is attributed to the hormonal imbalance disorders such as menopause. Hormone replacement therapy is suggested for replenishing the hormones when the level of hormones present in the body drops as compared to required standard levels for appropriate functioning of the body. The female human body go through various types of hormonal changes. Level of hormones get changed by growing age which leads to several disorders and diseases. Because of hormonal imbalance human need to face some challenges such as fatigue, muscle loss, memory decline, weight gain, and low libido. Increasing number of females having menopause is impelling the market. Starting age of menopause in women is around 45 to 50 years. In this hormonal level of estrogen and progesterone decrease significantly in women. Request Sample link :- https://growthmarketreports.com/request-sample/673 Market Trends, Drivers, Restraints, and Opportunities  Growing awareness about post-menopausal hazards and increase in number of menopausal women are anticipated to drive the market expansion. Increasing prevalence of menopausal disorder and development in drug delivery systems with increased effectiveness are expected to fuel the market expansion in the coming years. Growing adoption ofanti-aging therapy, untapped market of emerging economies are expected to offer significant opportunities for the market players. High cost of treatment and side effects of hormone replacement therapy are projected to hamper the market growth. Stringent regulations, product recalls and delay in FDA approvals are anticipated to impede the growth of the market.    

  2. Market Segment Insights: Estrogen segment is projected to hold a key market share In terms of products, the hormone replacement therapy market is segmented into estrogen, human growth, thyroid, and testosterone. The estrogen hormone replacement therapy segment dominated the market share and is expected to hold a key share of the market during the forecast period. During hysterectomy or post-menopause in women the estrogen replacement therapy is used for maintaining the hormonal balance. For generating huge number of prescriptions estrogen- based product is studied which makes the segment largest. On the other hand, the human growth hormone replacement therapy segment is anticipated to expand at a rapid pace during the forecast period due to increasing prevalence of growth deficiencies, mainly in children. Based on survey conducted by WHO, around 15 million infants are born premature and about 85% of these newborns are not developed completely. In adults, for the treatment of pituitary tumors and short bowel syndrome the hormone replacement therapy is used. Enquiry Link :-https://growthmarketreports.com/enquiry-before-buying/673 Competitive Landscape Key players competing in the hormone replacement therapy market includes Abbott Laboratories, Novartis, Pfizer Inc., Mylan Laboratories, Merck and Co., Novo Nordisk, Bayer Healthcare, Eli Lilly, and Genentech. Key players are implementing business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance, in February 2015, Famy Care was acquired by Mylan Laboratories. After this acquisition Mylan started the female health business including the production of hormone replacement drugs, Intra-Uterine Devices (IUD), and contraceptives. About Growth Market Reports: GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact: Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com Follow Us: LinkedIn | Twitter

More Related